drugset / Trial / NCT00223093

TAIZ -Monocytes for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)

NCT00223093 ↗

Phase 1 Unknown 10 enrolled University Hospital Schleswig-Holstein
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Induce tolerance or reduce the amount of immunosuppression after renal transplant patient (receiving cadaver kidney)with so called TAIZ-monocytes

Timeline

Start
2004-02
Primary completion
—
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject TAIZ-monocytes Cell therapy — —

Indications

No indication recorded.